Condensed Consolidated Statements of Cash Flows $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Cash Provided by (Used in) Operating Activities
Net earnings (losses)	$ 224	$ 3,074	$ 851
Adjustments to reconcile net earnings (losses) to operating cash flows:
Depreciation and amortization		163	190
Deferred income tax provision (benefit)		(550)	(1,180)
(Income) losses from investments in equity securities	2,478	3,707	5,789
Dividends from ABI		104	119
(Gain) loss on Cronos-related financial instruments	0	14	128
Loss on early extinguishment of debt	0	0	649
Cash effects of changes:
Receivables		(5)	(7)
Inventories		88	118
Accounts payable		(27)	3
Income taxes		49	(200)
Accrued liabilities and other current assets		(382)	(104)
Accrued settlement charges		(618)	(568)
Pension plan contributions		(11)	(23)
Pension and postretirement (income) cost, net		(110)	(127)
Other, net		141	104
Net cash provided by (used in) operating activities		5,637	5,742
Cash Provided by (Used in) Investing Activities
Capital expenditures		(147)	(102)
Other, net		(68)	60
Net cash provided by (used in) investing activities		(215)	(42)
Cash Provided by (Used in) Financing Activities
Long-term debt issued		0	5,472
Long-term debt repaid		(1,105)	(6,542)
Repurchases of common stock		(1,451)	(972)
Dividends paid on common stock		(4,908)	(4,787)
Premiums and fees related to early extinguishment of debt		0	(623)
Other, net		(12)	(216)
Net cash provided by (used in) financing activities		(7,476)	(7,668)
Cash, cash equivalents and restricted cash:
Increase (decrease)		(2,054)	(1,968)
Balance at beginning of period		4,594	5,006
Balance at end of period	2,540	2,540	3,038
Cash and cash equivalents	2,483	2,483
Restricted cash included in other current assets	15	15
Restricted cash included in other assets	42	42
Cash, cash equivalents and restricted cash	$ 2,540	$ 2,540	$ 3,038